Maternal hormonal contraceptive use and childhood central nervous system tumor risk in a large Scandinavian cohort
Caroline H Hemmingsen(Danish Cancer Society), Marie Hargreave(Danish Cancer Society), René Mathiasen(Copenhagen University Hospital), Susanne K. Kjær(Copenhagen University Hospital), Lina Steinrud Mørch(Danish Cancer Society), Ulrika Nörby(Stockholm Health Care Services), Maarit K. Leinonen(University of Helsinki), Anton Pottegård(Odense University Hospital), Hedvig Nordeng(University of Oslo), Charlotte Wessel Skovlund(Danish Cancer Society), Sarah Hjorth(University of Oslo)
Cited by 0
Related Papers
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
|The Lancet|2019|1.3k
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
|The Lancet Infectious Diseases|2015|638
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
|The Lancet Oncology|2017|510
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
|The Lancet Oncology|2013|434
Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort
|International Journal of Epidemiology|2020|280